3-160258644-GAAAA-GAAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000326448.12(IFT80):c.2224-10del variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0246 in 1,510,686 control chromosomes in the GnomAD database, including 528 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.033 ( 115 hom., cov: 0)
Exomes 𝑓: 0.024 ( 413 hom. )
Consequence
IFT80
ENST00000326448.12 splice_polypyrimidine_tract, intron
ENST00000326448.12 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.523
Genes affected
IFT80 (HGNC:29262): (intraflagellar transport 80) The protein encoded by this gene is part of the intraflagellar transport complex B and is necessary for the function of motile and sensory cilia. Defects in this gene are a cause of asphyxiating thoracic dystrophy 2 (ATD2). Three transcript variants encoding two different isoforms have been found for this gene.[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 3-160258644-GA-G is Benign according to our data. Variant chr3-160258644-GA-G is described in ClinVar as [Likely_benign]. Clinvar id is 215528.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-160258644-GA-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0636 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFT80 | NM_020800.3 | c.2224-10del | splice_polypyrimidine_tract_variant, intron_variant | ENST00000326448.12 | NP_065851.1 | |||
TRIM59-IFT80 | NR_148401.1 | n.2932-10del | splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFT80 | ENST00000326448.12 | c.2224-10del | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_020800.3 | ENSP00000312778 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0334 AC: 4948AN: 147952Hom.: 115 Cov.: 0
GnomAD3 genomes
AF:
AC:
4948
AN:
147952
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0282 AC: 5278AN: 187270Hom.: 89 AF XY: 0.0264 AC XY: 2673AN XY: 101404
GnomAD3 exomes
AF:
AC:
5278
AN:
187270
Hom.:
AF XY:
AC XY:
2673
AN XY:
101404
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0236 AC: 32168AN: 1362642Hom.: 413 Cov.: 32 AF XY: 0.0229 AC XY: 15541AN XY: 677994
GnomAD4 exome
AF:
AC:
32168
AN:
1362642
Hom.:
Cov.:
32
AF XY:
AC XY:
15541
AN XY:
677994
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0335 AC: 4959AN: 148044Hom.: 115 Cov.: 0 AF XY: 0.0327 AC XY: 2354AN XY: 72038
GnomAD4 genome
AF:
AC:
4959
AN:
148044
Hom.:
Cov.:
0
AF XY:
AC XY:
2354
AN XY:
72038
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Jeune thoracic dystrophy Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at